Disclosed is a compound as a fibroblast growth factor receptor 4 (FGFR4) inhibitor (as shown in formula (I)), and a pharmaceutical composition thereof and a preparation method therefor, as well as the use of same in the treatment of FGFR4-mediated diseases. The above-mentioned compounds act by participating in a number of processes, such as regulating cell proliferation, apoptosis, migration, neovascularization.
本发明公开了一种作为成纤维细胞生长因子受体 4(FGFR4)
抑制剂的化合物(如式(I)所示)及其药物组合物和制备方法,以及其在治疗 FGFR4 介导的疾病中的用途。上述化合物通过参与一系列过程发挥作用,如调节细胞增殖、凋亡、迁移、新生血管形成等。